Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-06-29

Clinical Trial Update: OPTIMA Bi-ventricular Capture Verification Study

View source ↗

Summary

The OPTIMA Bi-ventricular Capture Verification Study (NCT00887055) sponsored by Guidant Corporation has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Guidant Corporation | Conditions: Heart Failure | Status: WITHDRAWN